Phathom Pharmaceuticals, Inc. announced that it has appointed Todd Branning as Chief Financial Officer. Branning was most recently with Amneal Pharmaceuticals, Inc. where he served as Senior Vice President and Chief Financial Officer. He brings a diverse global finance background consisting of over 25 years of experience in corporate finance and accounting, tax, financial planning and analysis, and investor relations. As SVP, CFO at Amneal Pharmaceuticals, he helped to build, leverage, and optimize infrastructure following the completion of a transformational merger in May 2018. Prior to Amneal Pharmaceuticals, he served as Senior Vice President, Chief Financial Officer for Teva Pharmaceuticals' Global Generic Medicines division.